Literature DB >> 1112646

Selective arterial embolization for the control of traumatic splenic bleeding.

V P Chuang, S R Reuter.   

Abstract

Artificial splenic trauma was created and treated with embolic material injected selectively into the splenic artery in 10 dogs. The bleeding was controlled by the original or a repeat embolization within the first 3 hours in all dogs. Seven dogs survived for 2 months. On angiograms performed prior to sacrifice, the arteries supplying the infarcted section of the spleen were again patent. Although both the arterial branches and the amount of splenic parenchyma in the area of infarction were smaller, the area of artificial trauma could not otherwise be identified. The histologic examination of the area of injury indicated healing of the injury and resolution of the infarct. The results of the study would indicate that selective embolization is a feasible method of controlling bleeding from splenic injury. Although embolism would not replace splenectomy as the generally used method, it could be used in patients who were not otherwise candidates for operative splenectomy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1112646     DOI: 10.1097/00004424-197501000-00003

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  4 in total

1.  Intraparenchymal Doppler ultrasound after proximal embolization of the splenic artery in trauma patients.

Authors:  Johann B Dormagen; Christine Gaarder; Leiv Sandvik; Pål A Naess; Nils E Kløw
Journal:  Eur Radiol       Date:  2008-02-15       Impact factor: 5.315

2.  Selective arterial embolization in traumatic hemobilia.

Authors:  M L Nielsen; T Mygind
Journal:  World J Surg       Date:  1980-05       Impact factor: 3.352

3.  Splenic embolization.

Authors:  D G Spigos; W S Tan; M F Mozes; K Pringle; I Iossifides
Journal:  Cardiovasc Intervent Radiol       Date:  1980       Impact factor: 2.740

Review 4.  Splenic artery embolization: technically feasible but not necessarily advantageous.

Authors:  F Van der Cruyssen; A Manzelli
Journal:  World J Emerg Surg       Date:  2016-09-13       Impact factor: 5.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.